However, only knockdown of KIF11 resulted in a markedly reduced tumor cell proliferation in Ben-Men-1 cells and the newly established anaplastic NF2-mutated meningioma cell line NCH93, proposing KIF11 as a novel prognostic marker and therapeutic target. Here, KIF11 is linked to meningioma.